How has been the historical performance of Khyati Multimed.?
Khyati Multimed has seen net sales grow from 0.05 Cr in Mar'23 to 1.87 Cr in Mar'25, but rising expenditures led to significant losses, with an operating profit of -1.27 Cr and a negative EPS of -0.84 in Mar'25, indicating ongoing financial struggles since at least Mar'21.
Answer:The historical performance of Khyati Multimed shows a significant increase in net sales over the years, with figures rising from 0.05 Cr in Mar'23 to 1.87 Cr in Mar'25. However, the company has consistently faced challenges with its expenditures, which have also increased, leading to negative operating profits. In Mar'25, the total expenditure reached 3.14 Cr, resulting in an operating profit of -1.27 Cr. The profit before tax for the same period was -1.28 Cr, and the profit after tax was -0.91 Cr. This trend of losses has been evident since at least Mar'21, with net profits fluctuating but remaining negative. The earnings per share (EPS) in Mar'25 was -0.84, reflecting the company's ongoing financial struggles.Breakdown:
Khyati Multimed's financial trajectory indicates a gradual increase in net sales, climbing from 0.05 Cr in Mar'23 to 1.87 Cr in Mar'25, but this growth has been overshadowed by rising expenditures, which totaled 3.14 Cr in Mar'25. The company's operating profit margin has deteriorated significantly, showing a margin of -67.91% in Mar'25, compared to a positive margin of 12.5% in Mar'24. The company has reported losses in profit before tax and profit after tax for several years, with Mar'25 figures at -1.28 Cr and -0.91 Cr, respectively. The negative EPS of -0.84 in Mar'25 further underscores the financial difficulties faced by Khyati Multimed, which has not achieved profitability since at least Mar'21.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
